Femstat 3 Side Effects
Generic Name: butoconazole topical
Note: This document contains side effect information about butoconazole topical. Some of the dosage forms listed on this page may not apply to the brand name Femstat 3.
For the Consumer
Applies to butoconazole topical: intravaginal cream
Side effects include:
Vulvar/vaginal burning, itching, soreness and swelling, pelvic or abdominal pain or cramping.
For Healthcare Professionals
Applies to butoconazole topical: vaginal cream
Genitourinary
Common (1% to 10%): Vulvar/vaginal burning, itching, soreness, swelling; pelvic pain or cramping[Ref]
Local
Frequency not reported: Irritation[Ref]
Gastrointestinal
Common (1% to 10%): Abdominal pain or cramping[Ref]
Nervous system
Frequency not reported: Headache[Ref]
Hematologic
Thrombocytopenia developed 1 week after beginning this drug. It resolved slowly over the next few weeks after drug discontinuation.[Ref]
Frequency not reported: Thrombocytopenia[Ref]
References
1. Brown D Jr, Henzl MR, LePage ME, Tsao LL, Izu AE, Walker KA, Adamson GD, Droegmuller W "Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo." J Reprod Med 31 (1986): 1045-8
2. Ruf H, Vitse M "A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis." J Int Med Res 18 (1990): 389-99
3. "Butoconazole or vulvovaginal candidiasis." Med Lett Drugs Ther 28 (1986): 68
4. "Product Information. Femstat (butoconazole)." Syntex Laboratories Inc, Palo Alto, CA.
5. Maloley PA, Nelson E, Montgomery HA, Campbell JR "Severe reversible thrombocytopenia resulting from butoconazole cream." DICP 24 (1990): 143-4
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about Femstat 3 (butoconazole topical)
Consumer resources
Other brands: Gynazole-1
